. Experiments using our framework can easily accommodate up to five cell lines screened in parallel in four different conditions, or one cell line screened in up to 20 different conditions, in three replicates, respectively. As such, the setup is also ideally suited to append a panel of reference treatments to cross-reference metabolic responses elicited by uncharacterized test compounds with metabolic phenotypes of interest. (a) A TECAN Spark 10M plate reader is used to monitor cell growth by automatically acquiring bright-field images of a 96-well microtiter plate. Confluence was estimated on-line by segmenting the percentage area of the well covered by cells (i.e. green area), using a manufacturer-proprietary algorithm. (b) Schematic workflow for metabolome sampling procedure. Two replicate plates are processed at each sampling time-point: one to collect cell extracts (left branch) and a second one to measure the extracted cell number, necessary for subsequent normalization of metabolite intensities (right branch). Metabolome profiles are generated using a non-targeted mass spectrometry platform, while cell numbers are estimated from automated microscopy imaging.
Supplementary Figure 2. Schematic description of MS data normalization and analysis. (a)
To profile dynamic metabolic changes in mammalian cells induced by small-molecule treatments, we adapted an experimental workflow from 1 and used flow-injection analysis coupled to time-of-flight mass spectrometry (TOFMS) as described in 2 . This method omits chromatographic separation and allows the automated injection of cell extract samples into a constant solvent flow and direct delivery to an Agilent 6550 QTOFMS instrument. (b) We annotated detected ions to known metabolites listed in Recon2 and HMDB (for the full list of annotated metabolites see Supplementary Data 1) based on their accurate mass and by assuming that deprotonation is the most frequent and reliable form of ionization in negative mode. (c) To normalize raw MS spectra a linear model was used to decouple the variance in the data caused by differences in extracted cell numbers (quantified by means of time lapse microscopy), intrinsic noise of the instrument and drug treatment effects. It is worth noting, that because we estimate relative changes of metabolites within the same cell lines after drug exposure, we can directly adopt confluence measurements to correct for differences in the amount of extracted cells between time-points. Compared to alternative measurements of cell numbers 3 , cell volume 4 and cell protein content 5 , time-lapse microscopy offers accurate measurements of confluence and bypasses the need for additional experimental steps (e.g. staining, trypsinization). (d) Data analysis and interpretation consists of three main steps. To extract differences in the baseline metabolite levels across the different cell lines, we first group cell lines based on the similarity in their metabolome profiles using Spearman pairwise correlation and an affinity propagation algorithm 6 . In parallel, principal component analysis is used to identify the major patterns in the data. Metabolites associated to each principal component (PC) are individuated by calculating the Spearman correlation between each metabolite and PC. We retained only those ions with a Spearman correlation larger or equal to 0.7 to at least one PC. (e) Secondly, we investigate commonality and diversity in the metabolic response across cell lines to the same treatments. In the former case, for each individual metabolite time course we calculated the median of the maximum absolute fold changes and the product of lowest p-values across cell lines. On the other hand, Metabolites that exhibit cell line-specific responses to a given perturbation are selected on the basis of their response variability across different cell lines. The standard deviation for each metabolite is calculated from the aforementioned maximum fold changes, and metabolites with a standard deviation ≥ 1.5 are retained. (f) Metabolites associated to the aforementioned groups are tested against KEGG metabolic pathways to search for overrepresented metabolic processes. Significance is estimated by classical hypergeometric tests and correction for multiple test was applied 7 . Here, the average cell size during unperturbed growth remained largely constant in time, up to a confluence of approximately 80%. Above 80% confluence, cells become difficult to segment and we observed a slight cell shrinkage. As a consequence, reliably estimating the extracted cell number above 80% cell confluence is difficult, and we excluded all metabolome measurements taken above this cell density threshold from data analysis. Pearson correlation between pairs of biological replicates was estimated by comparing Z-score intensities across all cell lines and conditions (reported on the upperright corner of each subplot). The robustness and repeatability of metabolome profiles obtained with our experimental platform is illustrated by bivariate histograms (the matlab function histogram2 was used). In each plot, Z-score values from two biological replicates are plotted against each other. The 2D-histograms reveal the underlying shape and density of the distribution and give a visual perspective on the correlation between replicates. In in each panel, we reported ~100.000 points corresponding to the normalized Z-score of all annotated ions across all conditions and time points. There is only a minor fraction (< 5%) of metabolites that exhibit a difference in Z-score between two replicates larger than 2.
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Supplementary Figure 6. Cell line doubling times.
For each cell line in normal untreated condition, the doubling time was estimated from the exponential fit of confluence measurements between 20 and 80% ( Figure 1 in the main text) . The plot shows a comparison of our growth rate estimates to previously experimentally measured ones 9 . Overall, the determined growth rates of the five ovarian cancer cell lines vary from 20 to approximately 40 hours doubling time, and are in good agreement with previous NCI growth-rate measurements. It is worth noting that we used dialyzed FBS as a medium supplement. The absence of the low-molecular weight fraction of the serum might explain the observed slight differences in growth rates.
Supplementary Figure 7. Analysis of steady-state metabolic profiles in ovarian cancer cells. (a)
Spearman pairwise metabolome similarity across the five cell lines. Spearman correlation was calculated between Z-score normalized metabolome profiles of cell line pairs. To avoid any a priori definition of the number of clusters, we adopted an affinity propagation algorithm 6 . The affinity propagation algorithm detected two major groups of cell lines based on metabolome similarity, separated by the dashed white lines. (b) Principal component analysis results. In order to identify major trends in the full metabolome data set, we performed principal component analysis (pca function in Matlab) and subsequently determined four groups of metabolites, by correlating metabolite levels in the five cell lines to each individual principal component (Spearman correlation ≥ 0.7) ( Table  S1 ). The first principal component explains 43% of the variance in the data. (c) Pathway enrichment analysis. Each row corresponds to a metabolic pathway, while each column represents metabolites associated to one of the four principal components. We tested the four groups of metabolites identified in step (b) for an overrepresentation of metabolites in KEGG metabolic pathways, using a hypergeometric test and p-value correction for multiple tests (pathway enrichment analysis) 7, 10 Only pathways with q-value ≤ 0.001 are considered. The first two components exhibit statistically significant enrichment for metabolites in specific metabolic pathways, while the remaining PCs consist of more heterogeneous metabolites, and no statistical enrichment for metabolic pathways was identified. (d) Z-scores of α-values associated to metabolites in central carbon metabolism. Metabolites marked in red are α-keto acids that were detected as phenyl hydrazine derivatives. The analysis of relative metabolite abundances (α-values) across the five ovarian cancer cell lines revealed heterogeneous metabolome patterns. We detected an overall tendency to form two main groups, differentiating OVCAR3 and IGROV1 from OVCAR4, OVCAR8 and SKOV3 (panel a). Principal component analysis revealed that a large portion of metabolites exhibited a larger pool size in OVCAR3 and IGROV1 with respect to the three remaining ovarian cancer cell lines (i.e. first principal component in panel b). Furthermore, we found that metabolites with higher levels in OVCAR3 and IGROV1 were significantly overrepresented (q-value ≤ 0.001) in fatty acid and central carbon metabolism (panel c-d) . Recent studies 11, 12 have unraveled that more invasive ovarian cancer cells, like OVARC8 and SKOV3, exhibit a drastically different utilization of nutrients with respect to lowinvasive OVCAR3 and IGROV1 cells. In particular, high-invasive ovarian cancer cells depend on glutamine as an essential anaplerotic substrate to drive tricarboxylic acid (TCA) cycle 11, 12 . We found that intermediates in glycolysis (e.g. glyceraldehyde 3-phosphate, phosphoenolpyruvate) and TCA cycle (e.g. citrate, 2-oxoglutarate) are more abundant in low-invasive than in high-invasive ovarian cancer cells (panel d). This finding is consistent with previous data 12 , and possibly reflect the described shift from glycolysis to oxidative phosphorylation in highinvasive cancer cells 12 . Moreover, pathway enrichment analysis revealed major differences in fatty acid metabolism (panel c), in agreement with an up-regulation of monoglycerol lipase and fatty acid metabolism in invasive cancer cells such as SKOV3 and OVCAR8 13 . Overall, our method is capable of recapitulating several metabolic features differentiating invasive from non-invasive ovarian cancer cells, and expands cell line characterization by a multi-parametric phenotypic readout comprising several hundreds of metabolic species. 
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